13F-HR filed by Atlas Venture Life Science Advisors, LLC
Atlas Venture Life Science Advisors, LLC filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-05-16, with 16 holding rows worth $1,088,761,000.
- Accession
- 0001387131-22-006198
- Filer
- CIK 1917529
- Filed
- 2022-05-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 16 entries on the cover page, a total value of $1,088,761,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,088,761,000 with VALUE read as thousands by filing date, 13F file number 028-22531. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| KYMERA THERAPEUTICS INC | 501575104 | COM | 6,875,698 | $436,538,000 | thousands by filing date | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 8,201,638 | $138,198,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 8,934,902 | $106,236,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 3,209,627 | $86,981,000 | thousands by filing date | |
| IKENA ONCOLOGY INC | 45175G108 | COM | 5,018,178 | $62,928,000 | thousands by filing date | |
| GENERATION BIO CO | 37148K100 | COM | 8,278,876 | $58,614,000 | thousands by filing date | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 2,232,251 | $47,212,000 | thousands by filing date | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 2,759,344 | $44,150,000 | thousands by filing date | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 3,103,879 | $36,595,000 | thousands by filing date | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 4,520,863 | $17,405,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 1,031,160 | $16,509,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 3,476,536 | $15,401,000 | thousands by filing date | |
| GEMINI THERAPEUTICS INC | 36870G105 | CMN | 5,254,365 | $15,290,000 | thousands by filing date | |
| F-STAR THERAPEUTICS INC | 30315R107 | COM | 599,524 | $3,010,000 | thousands by filing date | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 222,976 | $1,913,000 | thousands by filing date | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 90,072 | $1,781,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001387131-22-006198 | this filing | 2022-05-16 | acceptance time not in the bulk data set |